Volume 5, Emitir 2 (2015)
Perspectiva da Trilha Clínica
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Metodologia da Trilha Clínica
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Resultados da Trilha Clínica
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Avaliação de Medicamentos
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Resultados da Trilha Clínica
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Resultados da Trilha Clínica
Antibiotic treatment in exacerbations of chronic obstructive pulmonary disease: recent trial results
Kavina Manalan, Taslima Rashid & Aran Singanayagam
Avaliação de Medicamentos
Omalizumab for the treatment of atopic dermatitis
Ibon Eguiluz-Gracia, Teresa Robledo-Echarren, Ricardo Suarez-Fernandez, Montserrat Fernandez-Rivas & Silvia Sanchez Ramon
